Recently, the pharmaceutical sector has changed frequently, and China Pharmaceutical, Xinhua Pharmaceutical and other stocks have won enough eyeballs
.
At the same time, a number of pharmaceutical companies have suspended trading, and the reason is that abnormal trading in the fluctuation of the price and decrease is suspended
.
Among them, Anpaco Biomedical Technology (ANPC) suspended trading at 09:56:41 EST on December 15, and resumed trading
at 10:01:41 on the same day.
The reason for the suspension is abnormal fluctuations in the price and decrease, and trading is suspended
.
Ampec Biomedical Technology is a biotechnology company
operating in China and the United States, focusing on early cancer screening and detection.
It is reported that the company sells a multi-cancer screening and detection test technology, using its innovative patented CDA technology and patented CDA equipment
.
In addition to early cancer screening and detection, CDA technology has shown potential
to help doctors diagnose and predict recurrence.
According to the 2021 financial report, Ampec Biomedical Technology achieved operating income of 17.
986 million yuan in 2021, a year-on-year decrease of 12.
30%; The net loss attributable to the parent company was 119 million yuan, the loss expanded by 47.
49% year-on-year, and the basic earnings per share were -8.
72 yuan
.
In addition, according to the company's unaudited financial results for the first quarter ended March 31, 2022, total revenue for the first quarter of 2022 was approximately RMB2 million, down 9.
9% from approximately RMB2.
2 million in the same period in 2021; The net loss in the first quarter of 2022 was approximately RMB14.
9 million, compared to a net loss of approximately RMB29.
3 million in the same period in 2021, a decrease of 49.
1%
from the same period in 2021.
The average selling price ("ASP") for CDA-based testing was RMB233 (US$36.
8) in the first quarter of 2022, down RMB168.
0, or 41.
9%, from RMB401.
0 in the same period in 2021, primarily due to the Company's focus on lower-priced more traditional cancer testing
.
As of March 31, 2022, APEC Biotech has contacted 27,254 customers who use CDA for testing in China and received substantial feedback
from 16,052 examined persons regarding health status and disease development.
In addition, Jiuzhou Pharmacy (CJJD) suspended trading at 14:07:47 EST on December 14, and resumed trading at 14:12:47 on the 14th, and the reason for the suspension was also the suspension
of abnormal trading with fluctuations.
Jiuzhou Pharmacy is a pharmacy
dedicated to the distribution and retail of pharmaceuticals and other health care products.
The Company operates through the following business segments: Retail Pharmacy, Online Pharmacy; Wholesale of medicines and cultivation
of herbs.
Among them, the retail pharmacy business sells prescription and over-the-counter drugs, dietary supplements, medical devices, and sundries to retail customers; The online pharmacy business provides over-the-counter drugs, dietary supplements, medical devices, and sundries to customers through multiple third-party platforms; The wholesale pharmaceutical business includes the provision of prescriptions to the Company's own retail pharmacies; In the herbal cultivation business, the company grows selected herbs and sells them to other drug sellers
.
The company is headquartered in Hangzhou
, China.
Recently, the stock price of Jiuzhou Pharmacy has risen significantly, rising nearly 30% intraday on December 9, soaring more than 51% on December 10, and more than 45%
intraday on December 12.
Some analysts pointed out that the recent sharp rise in Chinese concept stocks is mainly related
to the sharp increase in people's demand for drugs and epidemic prevention products after the optimization of epidemic prevention policies.
From the public information, these days, including Lianhua Qingwen, antigen detection reagents, ibuprofen and other drugs and devices have set off a rush to buy, some products are even in short supply, these demand will directly stimulate the rise in the stock price of related concept stocks
.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
